This study aims to measure the extent that individuals are feeling lonely and/or socially isolated using a brief eSurvey including validated questions (UCLA-3-item loneliness scale & ONS Direct measure of loneliness). Data collected will be used to create a 'heat map' of loneliness at local authority, city & regional levels to drive evidence-based commissioning decisions.

The Discover Me study aims to collect health and genetic data from consenting study participants to create a dynamic research resource.  The resource will facilitate research to help us better understand genetic risk of disease susceptibility and severity, as well as insights into drug response and adverse events in the primary care setting.  This will provide a research framework to integrate genetic information into primary care in the future.

Atrial fibrillation (AF) is a heart condition that causes irregular heartbeat. It affects up to 1 in 10 people over the age of 65. AF greatly increases risk of stroke, but treatment with blood thinning (“anticoagulant”) medication can stop this happening. About 10% of strokes happen in people unaware they have AF. Detecting AF can be difficult because it often comes and goes, and may not cause symptoms.

Many clinicians think the NHS should promote AF screening. The UK National Screening Committee has highlighted a lack of evidence that detecting AF in people by screening would benefit them.

We are therefore undertaking a large 8-year programme of work to find out if screening for AF in people aged 65 and over does prevent stroke and other problems like heart attacks, does not cause significant harm, and represents good value-for-money for the NHS. The SAFER Trial is a cluster randomised trial that will address these questions.

General practice is under pressure due to increasing workload and a shortage of GPs and other primary care staff. New forms of practice are also emerging.  Our aim is to explore how the composition of GP teams, and the relationships among team members (called team climate) affects the quality of care and health outcomes for patients, and the costs for the practice. 

OpenPROMPT aims to understand the impact of long COVID on quality-of-life in adults in English primary care.

One way of assessing the impact of long COVID is to measure quality-of-life through a standard questionnaire, which can then be used to understand the costs of long COVID to the NHS and wider economy.

The impact of long COVID on these measures is not currently known.  It is important to understand who is worst affected by long COVID and the cost to the NHS, so that strategies like booster vaccines can be prioritised to the right people.

The primary aim of the trial is to improve the diagnosis of DDH  in primary care by: 

a) reducing the number of ‘clinically  insignificant’ referrals to secondary care and

b) reducing the number of infants with a missed or late  diagnosis of DDH